, Volume 39, Issue 4, pp 341–352 | Cite as

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria

  • W. Poeppl
  • M. Hell
  • H. Herkner
  • B. Stoiser
  • G. Fritsche
  • N. Schurz-Bamieh
  • G. Poeppl
  • R. Gattringer
  • N. Jones
  • M. Maass
  • A. Egle
  • H. BurgmannEmail author
Clinical and Epidemiological Study



To describe the clinical features, risk factors for severe disease and effectiveness of oseltamivir in patients with 2009 pandemic influenza A (H1N1) virus infection.


In a prospective, cross-sectional, multicentre study, data on 540 patients with confirmed 2009 H1N1 infection from seven Austrian hospitals were collected using a standardised online case-history form.


The median age of the patients was 19.3 years (range 26 days–90.8 years); point-of-care testing yielded false-negative results in 60.2% of the 176 cases tested. The most common symptoms were fever, cough, fatigue and headache. Overall, 343 patients (63.5%) were hospitalised, 49 (9.1%) were admitted to an intensive care unit (ICU) and 14 (4.1%) died. Case fatality rates were highest (9.1%) in those aged 65 years or older. Factors significantly associated with a higher risk for ICU admission included age, neurological disease, adipositas, and both interstitial pathology and lobular pathology on chest X-ray. No association with pregnancy, malignancy or immunosuppressive therapy was detected. Antiviral treatment significantly reduced the duration of fever by 0.66 days and lowered the risk of ICU admission, but had no significant benefit on survival.


During the 2009 H1N1 influenza pandemic, elderly or obese patients and those with neurological disease had an increased risk for severe H1N1 infection in Austria. Pregnancy was not associated with a higher risk for severe disease in the later phase of the 2009 H1N1 pandemic. Antiviral treatment provided a minimal effect on the symptoms of influenza but reduced the risk of admission to an ICU.


Influenza Pandemic H1N1 Risk factor 


Conflict of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507–17.PubMedCrossRefGoogle Scholar
  3. 3.
    Gilsdorf A, Poggensee G. Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill. 2009;14. pii=19318.Google Scholar
  4. 4.
    Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill. 2009;14. pii=19288.Google Scholar
  5. 5.
    Michaelis M, Doerr HW, Cinatl J Jr. An influenza A H1N1 virus revival—pandemic H1N1/09 virus. Infection. 2009;37:381–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009;14(22). pii=19227.Google Scholar
  7. 7.
    Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:941–7.Google Scholar
  8. 8.
    Chen M. World now at the start of 2009 influenza pandemic. World Health Organization (WHO). 2009.
  9. 9.
    Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–19.PubMedCrossRefGoogle Scholar
  10. 10.
    Austrian Federal Ministry of Health. Ein Jahr Neue Grippe—Die Maßnahmen des Gesundheitsministeriums. 2010.
  11. 11.
    Redlberger-Fritz M, Popow-Kraupp T. Rückblick auf die erste Welle der Influenza A/H1N1v-Pandemie 2009/2010. Virusepidemiologische Information 05/10. 2010.
  12. 12.
    Depoortere E, Mantero J, Lenglet A, Kreidl P, Coulombier D. Influenza A(H1N1)v in the southern hemisphere—lessons to learn for Europe? Euro Surveill. 2009;14. pii=19246.Google Scholar
  13. 13.
    Austrian Agency for Health and Food Safety (AGES). Zur Situation in Österreich. 2010.
  14. 14.
    Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ. 2010;182:257–64.PubMedCrossRefGoogle Scholar
  15. 15.
    Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925–34.PubMedCrossRefGoogle Scholar
  16. 16.
    Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896–902.PubMedCrossRefGoogle Scholar
  17. 17.
    Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361:1935–44.PubMedCrossRefGoogle Scholar
  18. 18.
    Santa-Olalla Peralta P, Cortes-García M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I, et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April–December 2009. Euro Surveill. 2010;15. pii=19667.Google Scholar
  19. 19.
    Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009). Thorax. 2010;65:645–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Bassetti M, Parisini A, Calzi A, Pallavicini FM, Cassola G, Artioli S, et al. Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. Clin Microbiol Infect. 2011;17:247–50. doi: 10.1111/j.1469-0691.2010.03275.x.PubMedCrossRefGoogle Scholar
  21. 21.
    Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, Farrell DJ, et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med. 2009;361:2000–1.PubMedCrossRefGoogle Scholar
  23. 23.
    Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945–52.PubMedCrossRefGoogle Scholar
  24. 24.
    Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375:1100–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Nicholson KG. Clinical features of influenza. Semin Respir Infect. 1992;7:26–37.PubMedGoogle Scholar
  26. 26.
    Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14. pii=19309.Google Scholar
  27. 27.
    Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302:1880–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888–95.PubMedCrossRefGoogle Scholar
  30. 30.
    White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A(H1N1). JAMA. 2009;302:1905–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Staudinger T. New flu (H1n1): phantom or intensive medicine super-GAU—a view from the Austrian reality. Wien Klin Wochenschr. 2010;122:3–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ. 2009;339:5213.CrossRefGoogle Scholar
  33. 33.
    [No authors listed]. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2009;84:481–4.Google Scholar
  34. 34.
    Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362:27–35.PubMedCrossRefGoogle Scholar
  35. 35.
    Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Lapinsky SE. Critical illness as a result of influenza A/H1N1 infection in pregnancy. BMJ. 2010;340:c1235.PubMedCrossRefGoogle Scholar
  37. 37.
    Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis. 2010;10:145.PubMedCrossRefGoogle Scholar
  38. 38.
    Tsigrelis C, Mohammad M, Fraimow HS, Dellinger RP, Marchesani D, Reboli AC. Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection. Infection. 2010;38:237–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010;134:235–43.PubMedGoogle Scholar
  40. 40.
    Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–4.Google Scholar
  41. 41.
    Keshet R, Boursi B, Maoz R, Shnell M, Guzner-Gur H. Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci. 2009;337:248–55.PubMedCrossRefGoogle Scholar
  42. 42.
    Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus—United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:826–9.Google Scholar
  43. 43.
    Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis. 2009;49:1090–3.PubMedCrossRefGoogle Scholar
  44. 44.
    Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • W. Poeppl
    • 1
    • 3
  • M. Hell
    • 2
  • H. Herkner
    • 1
  • B. Stoiser
    • 1
  • G. Fritsche
    • 4
  • N. Schurz-Bamieh
    • 5
  • G. Poeppl
    • 6
  • R. Gattringer
    • 7
  • N. Jones
    • 8
  • M. Maass
    • 9
  • A. Egle
    • 10
  • H. Burgmann
    • 1
    Email author
  1. 1.Department of Internal MedicineMedical University of ViennaViennaAustria
  2. 2.Department of Hospital Epidemiology and Infection ControlUniversity Hospital SalzburgSalzburgAustria
  3. 3.Department of Dermatology and Tropical MedicineMilitary Hospital ViennaViennaAustria
  4. 4.Department of Internal MedicineUniversity Hospital of InnsbruckInnsbruckAustria
  5. 5.Department of Internal MedicineHospital of the Barmherzigen SchwesternRied im InnkreisAustria
  6. 6.Department of PaediatricsRegional Hospital Kirchdorf an der KremsKirchdorf an der KremsAustria
  7. 7.Institute for Microbiology, Hygiene, and Tropical MedicineHospital of the ElisabethinenLinzAustria
  8. 8.Department of PaediatricsUniversity Hospital SalzburgSalzburgAustria
  9. 9.Institute of Medical Microbiology, Hygiene and Infectious DiseasesUniversity Hospital SalzburgSalzburgAustria
  10. 10.3rd Medical Department for Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectious DiseasesUniversity Hospital SalzburgSalzburgAustria

Personalised recommendations